Tag: antidepressants

A new study reveals that antidepressants, commonly prescribed to post-menopausal women, may increase risks of falls, cognitive decline, and cardiovascular issues, raising questions about their overuse in this population.

Tapering should be tailored and adjusted to the patient, slowed and more hyperbolic in people who have severe and longstanding reactions.

Justin Karter interviews Milutin Kostić on the fundamental flaws in depression research and its neglect of human complexity.

About half of the large antidepressant trials are biased enough to be considered “seeding trials,” according to the researchers.

Ayurdhi Dhar interviews psychiatrist Swapnil Gupta on psychiatric drug discontinuation, drug cocktail risks, patient choice, and the need for trust and transparency.

Research sheds light on the impact of antidepressants on sexual dysfunction, emphasizing the need for patient-physician communication.

While the study can’t confirm causality, it does contradict the notion that antidepressants reduce suicide at the population level.

New study reveals: 2 in 3 people need more than the current antidepressant benefits to consider them worthwhile.

New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.

The STAR*D Study has been cited as real-world evidence of the efficacy of antidepressants. In truth, it told of a failed paradigm of care.

A new study in Frontiers of Pharmacology finds that antidepressant use during pregnancy is linked to reduced motor skills in children at 2 years...

In adolescent depression treatment, those who received a placebo but thought they received Prozac improved more than those who received the drug and knew it.

In Part 2 of our reader Q&A podcast, MIA founder Robert Whitaker answers questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy.

Experts advocate limiting antidepressant use to only the most severe cases of depression, emphasizing the need for social and psychological interventions.

Researchers found that rats born to mothers given the antidepressant Prozac during pregnancy or breastfeeding exhibited varied behavioral and developmental effects, with implications for the understanding of antidepressant impacts during human pregnancies.

Selective publication bias in top psychiatry journals was not explained by the quality of the studies, but by financial ties to pharma.

Researchers find that SSRIs increase suicide attempts up to age 24, and have no preventative effect at any age, even for those at high risk of suicide.

For those with severe depression, inpatient CBT was effective but the adding antidepressants did not improve treatment outcomes.

The initial study, which has been used to promote antidepressants, employed outcome switching to hide poor results.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

In a study of people with borderline personality disorder, only ADHD stimulants were associated with a decrease in suicide.

Moncrieff et al. respond to the contradictory and, in some cases, false concerns raised by these critics of their serotonin review.

Genetic testing may help reduce the length of time people experience the harmful effects of antidepressant drugs, but it is not helpful for predicting efficacy.

World Psychiatry article challenges conventional antidepressant prescription practices.

A new Cochrane review details the lack of evidence for antidepressants in the treatment of chronic pain.